DICE Therapeutics, Inc. (DICE) Social Stream



DICE Therapeutics, Inc. (DICE): $47.55

0.03 (+0.06%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

D

Add DICE to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#364 of 387

in industry

DICE THERAPEUTICS INC (DICE) Price Targets From Analysts

Use the tables below to see what analysts covering DICE THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-12 3 $60 $41 $49 $47.55 3.05%
2022-05-13 3 $60 $33 $46.333 $47.55 -2.56%
2022-07-18 4 $60 $33 $44.75 $47.55 -5.89%
2022-08-13 4 $60 $34 $45 $47.55 -5.36%
2022-09-07 5 $60 $34 $43.4 $47.55 -8.73%
2022-09-23 6 $60 $34 $42.166 $47.55 -11.32%
2022-10-12 5 $54 $33 $41.8 $47.55 -12.09%
2022-10-13 5 $77 $54 $66 $47.55 38.8%
2022-11-10 5 $77 $54 $65.5 $47.55 37.75%
2022-11-15 6 $77 $54 $65.428 $47.55 37.6%
2023-02-08 6 $77 $54 $64.428 $47.55 35.5%
2023-03-16 7 $77 $54 $64.428 $47.55 35.5%
2023-04-25 7 $77 $49 $62.714 $47.55 31.89%
2023-05-12 8 $77 $49 $61.875 $47.55 30.13%
2023-05-15 8 $77 $54 $63 $47.55 32.49%
2023-05-22 9 $77 $54 $63.888 $47.55 34.36%
2023-06-06 10 $77 $38 $61.3 $47.55 28.92%
2023-06-20 10 $77 $38 $59 $47.55 24.08%
2023-06-21 11 $75 $48 $53.727 $47.55 12.99%

The Trend in the Analyst Price Target


DICE's average price target has moved down $8.15 over the prior 57 days.

Over the past 45 weeks, DICE's average upside potential has been 90.17%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-09-07 5 60 34 43.400 21.02 106.47%
2022-11-15 6 77 54 64.428 33.63 91.58%
2023-02-08 6 77 54 64.428 29.31 119.82%
2023-05-22 9 77 54 63.888 34.59 84.7%
2023-06-20 10 77 38 59.000 46.44 27.05%

DICE Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.82 1 0 10 0 0 11

The Trend in the Broker Recommendations


Over the past 20 months, DICE's average broker recommendation rating worsened by 1.18.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In terms of how DICE THERAPEUTICS INC fares relative to stocks in the small market cap category, note that its average analyst price target is higher than 1749.41% of that group.
  • In terms of how DICE THERAPEUTICS INC fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is greater than 341.98% of that group.
  • In the context of stocks in the small market cap category, DICE THERAPEUTICS INC's number of analysts covering the stock is greater than 1303.49% of them.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, DICE THERAPEUTICS INC's variance in analysts' estimates is lower than -505.93% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to DICE THERAPEUTICS INC are TRDA, VAXX, and GNLX.

Is DICE a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!